Daniel Albert Geller MD
Child & Adolescent Psychiatry, Psychopharmacology
Associate Professor, Psychiatry, Massachusetts General Hospital, Harvard Medical School
Join to View Full Profile
55 Fruit StYaw 6900 Child & Adolescent PsychiatryBoston, MA 02114
Phone+1 617-724-5600
Fax+1 617-726-5567
Dr. Geller is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1988 - 1992
Johns Hopkins University School of MedicineInternship, Transitional Year, 1987 - 1988
The University of Adelaide Faculty of Health SciencesClass of 1978
Certifications & Licensure
CA State Medical License 1989 - Present
MA State Medical License 1992 - 2026
MD State Medical License 1988 - 1992
American Board of Pediatrics Pediatrics
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
National Board of Physicians and Surgeons Child and Adolescent Psychiatry- National Board of Physicians and Surgeons Pediatrics
- National Board of Physicians and Surgeons Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2014, 2016-2017
Clinical Trials
- 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD Start of enrollment: 2011 Jul 01
- D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD) Start of enrollment: 2011 Jun 01
- Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Publications & Presentations
PubMed
- 1 citationsCanadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines fo...Michael Van Ameringen, Naomi A Fineberg, Arun Ravindran, Paul D Arnold, Serge Beaulieu
Journal of Psychiatric Research. 2026-08-01 - Editorial: Autism Spectrum Disorder and Obsessive-Compulsive Disorder.Erica Greenberg, Gagan Joshi, Daniel Geller
Journal of the American Academy of Child and Adolescent Psychiatry. 2026-02-01 - Moving beyond symptom subtypes: testing a common dimension of lifetime OCD symptoms.Abel S Mathew, Sarah L Garnaat, David R Strong, Nicole C R McLaughlin, Kathleen D Askland
CNS Spectrums. 2025-11-03
Grant Support
- 2/2-D-Cycloserine Augmentation Of CBT For Pediatric OCDNational Institute Of Mental Health2011–2012
- Obsessive-Compulsive Disorder (OCD) Collaborative Genetics Association StudyNational Institute Of Mental Health2009–2010
- Juvenile Onset OCD As A Meaningful Development SubtypeNational Institute Of Mental Health2003
- Juvenile Onset OCD As A Meaningful Development SubtypeNational Institute Of Mental Health1999–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
